BTK plays a key role in promoting different intracellular activation pathways, such as Akt/PKB (Proteinkinase B) which is a downstream effector of phosphoinositide 3-kinase (PI3K) (6), and acts as a regulator for CLL-cell survival and proliferation (7). This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.